Lopressor: Difference between revisions
Jump to navigation
Jump to search
Gerald Chi (talk | contribs) mNo edit summary |
Gerald Chi (talk | contribs) mNo edit summary |
||
| Line 3: | Line 3: | ||
{{CMG}} | {{CMG}} | ||
==[[Lopressor indications and usage|Indications and Usage]]== | ===[[Lopressor indications and usage|Indications and Usage]]=== | ||
==[[Lopressor dosage and administration|Dosage and Administration]]== | ===[[Lopressor dosage and administration|Dosage and Administration]]=== | ||
==[[Lopressor dosage forms and strengths|Dosage Forms and Strengths]]== | ===[[Lopressor dosage forms and strengths|Dosage Forms and Strengths]]=== | ||
==[[Lopressor contraindications|Contraindications]]== | ===[[Lopressor contraindications|Contraindications]]=== | ||
==[[Lopressor warnings and precautions|Warnings and Precautions]]== | ===[[Lopressor warnings and precautions|Warnings and Precautions]]=== | ||
==[[Lopressor adverse reactions|Adverse Reactions]]== | ===[[Lopressor adverse reactions|Adverse Reactions]]=== | ||
==[[Lopressor drug interactions|Drug Interactions]]== | ===[[Lopressor drug interactions|Drug Interactions]]=== | ||
==[[Lopressor use in specific populations|Use in Specific Populations]]== | ===[[Lopressor use in specific populations|Use in Specific Populations]]=== | ||
==[[Lopressor overdosage|Overdosage]]== | ===[[Lopressor overdosage|Overdosage]]=== | ||
==[[Lopressor description|Description]]== | ===[[Lopressor description|Description]]=== | ||
==[[Lopressor clinical pharmacology|Clinical Pharmacology]]== | ===[[Lopressor clinical pharmacology|Clinical Pharmacology]]=== | ||
==[[Lopressor nonclinical toxicology|Nonclinical Toxicology]]== | ===[[Lopressor nonclinical toxicology|Nonclinical Toxicology]]=== | ||
==[[Lopressor clinical studies|Clinical Studies]]== | ===[[Lopressor clinical studies|Clinical Studies]]=== | ||
==[[Lopressor how supplied storage and handling|How Supplied/Storage and Handling]]== | ===[[Lopressor how supplied storage and handling|How Supplied/Storage and Handling]]=== | ||
==[[Lopressor patient counseling information|Patient Counseling Information]]== | ===[[Lopressor patient counseling information|Patient Counseling Information]]=== | ||
==[[Lopressor labels and packages|Labels and Packages]]== | ===[[Lopressor labels and packages|Labels and Packages]]=== | ||
Revision as of 22:52, 12 March 2014
 | |
| Clinical data | |
|---|---|
| Trade names | Lopressor, Toprol-xl |
| AHFS/Drugs.com | Monograph |
| MedlinePlus | a682864 |
| [[Regulation of therapeutic goods |Template:Engvar data]] |
|
| Pregnancy category | |
| Routes of administration | Oral, IV |
| ATC code | |
| Legal status | |
| Legal status |
|
| Pharmacokinetic data | |
| Bioavailability | 12% |
| Metabolism | Hepatic via CYP2D6, CYP3A4 |
| Elimination half-life | 3-7 hours |
| Excretion | Renal |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| IUPHAR/BPS | |
| DrugBank | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEBI | |
| ChEMBL | |
| E number | {{#property:P628}} |
| ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
| Chemical and physical data | |
| Formula | C15H25NO3 |
| Molar mass | 267.364 g/mol |
| 3D model (JSmol) | |
| Melting point | 120 °C (248 °F) |
| |
| |
| (verify) | |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]